Medroxyprogesterone acetate

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Progestin derivative.

Half-lifeThis section has been translated automatically.

24-50 h or 30-40 days (with i.m. application).

IndicationThis section has been translated automatically.

Amenorrhoea.

Limited indicationThis section has been translated automatically.

Preparation for surgery (stop 12 weeks before surgery), otosclerosis, phlebitis, smokers > 30 years.

Dosage and method of useThis section has been translated automatically.

Hormone therapy: 5-10 mg/day p.o. in combination with oestrogens from the 16th to 26th day of the cycle; hormonal contraception: 150 mg during the first 5 days of the cycle deep i.m., repeated every 3 months.

PreparationsThis section has been translated automatically.

Clinofem, Farlutal

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer